The third quarter of 2021 illustrates the competitive advantage of Tesla due to its integrated business. In the midst of a chip shortage that trims the production of almost all automakers, Tesla still breaks the record in terms of production units. This article is the sequel to talk about Tesla’s economic moat that discussed brand power, direct sales, and low-cost producer.
Continue reading “Competitive Advantage of Tesla: Chapter II”Economic Moat of Tesla: Musk’s Relentless Effort
Tesla surely leads the way for the next-generation vehicles. It has the most advanced battery, most covered charger facility, cool car, price advantage, and strong brand. We will take a closer look at those aspects to get a better insight into the Economic Moat of Tesla.
Continue reading “Economic Moat of Tesla: Musk’s Relentless Effort”Competitive Advantage Analysis of Differentiation
Some investors may confuse differentiation products with a durable competitive advantage. They assume that the production and fixed costs could be distributed among different kinds of products, thus could sell their product lower than competitors. Well, is it true? Starting from this, we are going to develop some competitive advantage analysis of differentiation.
Continue reading “Competitive Advantage Analysis of Differentiation”Testing The Economic Moat of Amazon Stock
How far does Amazon leave its competitor? Or, does it? Testing the economic moat of Amazon Stock will allow us to get a better understanding of the largest retailer’s competitive advantage.
Continue reading “Testing The Economic Moat of Amazon Stock”Moderna Stock Analysis: Boost Your Portfolio?
Moderna is one of the most discussed companies in 2021 due to its COVID-19 vaccine. What makes it more special is, it is not a conventional one like AstraZeneca or SINOVAC. It is RNA – based. A messenger of life. And the potential expansion of this new kind of biotechnology is almost limitless. Through this Moderna stock analysis post, we bring you to reality.
Continue reading “Moderna Stock Analysis: Boost Your Portfolio?”PayPal Stock Analysis: Taming The Magic Card?
During Black Friday, the PayPal Buy Now Pay Later (BNPL) Program experienced a 400% surge from the previous year. Are these jumps could attract investors to hold or even buy its stock? Through Our PayPal Stock Analysis, we address that question.
Continue reading “PayPal Stock Analysis: Taming The Magic Card?”Intuitive Surgical Business Model: Da Vinci Code
Leonardo da Vinci is the first who performs an autopsy on the human body. That brave – and maybe a blasphemous decision by religion was taken in 1490. Hundreds of years later, the Da Vinci robot, under the Intuitive Surgical company, becomes the first robot that delivers surgery (with the man behind of course). We invite you to get closer to the Intuitive Surgical Business Model through this article. Spoiler alert: we love its recurring income.
Continue reading “Intuitive Surgical Business Model: Da Vinci Code”Downstream Oil Stock Analysis: Refineries are Fine
Oil is not only about Exxon or Chevron. Here we offer you an alternative. This downstream oil stock analysis opens you to a new investing perspective. To understand more about the oil industry, the energy that stands still till the end of time. No matter how green human mission.
Continue reading “Downstream Oil Stock Analysis: Refineries are Fine”Economies of Scale as Durable Competitive Advantage
Being a market leader is not always translated into a durable competitive advantage. This post will talk further about economies of scale as a durable competitive advantage. What is a common mistake regarding the economy of scale as an economic moat? How does economies scale create a layer of protection for business? We are here to answer this moat question.
Continue reading “Economies of Scale as Durable Competitive Advantage”Competitive Advantage of Amgen: November Update
The competitive advantage of Amgen, like any other pharma company, lies in its patent. We invite readers to take a look at this issue – deeper.
Continue reading “Competitive Advantage of Amgen: November Update”